Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer

NCT04337632 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

338

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Doxorubicin Hydrochloride Liposome Injection+carboplatin
DRUG: paclitaxel +carboplatin

Sponsor

Hunan Cancer Hospital